Scott Gazelle Receives RAHSR Achievement Award

G. Scott Gazelle, MD, MPH, PhD, ITA director emeritus and vice chair for Faculty Affairs in the Department of Radiology, has received the 2016 Radiology Alliance for Health Services Research Achievement Award. The award honors the achievements of an individual who has made significant contributions to the field of health services research in radiology. Gazelle … Read more

United States faces biggest burden of hepatitis C treatment costs before 2020

The cost of treating hepatitis C (HCV) is likely to decline dramatically over the next decade in the United States, not because of cuts in drug prices but because the population in need of treatment will shrink by 2020 as a majority of patients will already have been treated, according to research by Jagpreet Chhatwal of Massachusetts General Hospital and colleagues presented at the 2015 AASLD Liver Meeting in San Francisco last month.

Katy Lowry receives RSNA Research Resident Grant

Katy Lowry, MD has been awarded a RSNA Research Resident/Fellow Grant for 2015-2016. Dr. Lowry’s research will be centered around “Optimizing Breast Cancer Surveillance in Women with a Personal History of Breast Cancer”. Dr. Lowry started her affiliation with the ITA while in medical school.

A case for taking risks on drugs for the dying

Imagine you are diagnosed tomorrow with pancreatic cancer. The latest medical odds would give you a 6 percent chance of surviving more than five years. But if your doctor said you had prostate cancer — a disease with many more treatment options — then the likelihood of being alive in five years would skyrocket to 99 percent.

Clearly, the medical need is greatest for pancreatic cancer. So, you’d think that our regulatory system would adjust the drug approval process to raise the possibility of bringing life-changing drugs to patients.

You’d be wrong.

Tool helps with decision-making for fibroid management

Data are limited on outcomes of laparoscopic hysterectomy with morcellation in patients with unsuspected uterine sarcomas, which complicates discussions between physicians and patients about management of uterine fibroids. A shared clinical decision tool described in an article published in the European Journal of Obstetrics and Gynecology and Reproductive Biology may help in counseling patients about optimal management of large fibroids while taking into consideration risks and benefits as mandated by the Food and Drug Administration.

Primary aldosteronism screen cost-effective in resistant HTN

(HealthDay)—For patients with resistant hypertension (RH), computed tomography (CT) scanning followed by adrenal venous sampling (AVS) is a cost-effective screen for primary aldosteronism (PA), according to a study published online Nov. 10 in Circulation: Cardiovascular Quality and Outcomes.

Practice of Yoga reduces healthcare cost by 43%

Continuous practice of Yoga and meditation can help one to reduce the need for healthcare services by 43%, says a new study by Harvard-affiliated Massachusetts General Hospital Institute for Technology Assessment and the Benson-Henry Institute.